About Inhalation Sciences Sweden AB 
Inhalation Sciences Sweden AB
Pharmaceuticals & Biotechnology
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
Company Coordinates 
Company Details
Halsovagen 7, Novum Floor 6, Elevator E , HUDDINGE None : 141 57
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Mar 2025)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
SEK 16 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.77
-64.45%
1.23






